serine peptidase inhibitor, Kazal type 5
| UniProt | Protein Name |
|---|---|
| Q148R4 |
|
| GO Term | Evidence Code | PMID |
|---|---|---|
| negative regulation of antibacterial peptide production |
|
|
| epidermal cell differentiation | ||
| cell differentiation | ||
| regulation of cell adhesion | ||
| negative regulation of proteolysis |
| GO Term | Evidence Code | PMID |
|---|---|---|
| extracellular region | ||
| extracellular region | ||
| cytoplasm | ||
| endoplasmic reticulum | ||
| endoplasmic reticulum membrane |
| GO Term | Evidence Code | PMID |
|---|---|---|
| serine-type endopeptidase inhibitor activity | ||
| serine-type endopeptidase inhibitor activity | ||
| peptidase inhibitor activity |
| Gene Ontology |
|---|
| calcium ion binding |
| InterPro |
|---|
| Kazal domain superfamily |
| Kazal domain |
| DO ID | Disease Name | Source |
|---|---|---|
| DOID:0050474 | Netherton syndrome |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
This work is licensed under Creative Commons Attribution 4.0 International
GlyCosmos Portal v4.5.0
Last updated: April 6, 2026